Efficacy and safety of upadacitinib maintenance therapy in patients with moderately to severely active Crohn’s disease: 2-year results from the U-ENDURE Long-Term Extension study
Authors
Ana Paula Lacerda (ORCID: https://orcid.org/0000-0002-0122-4183)
Efficacy and safety of upadacitinib maintenance therapy in patients with moderately to severely active Crohn’s disease: 2-year results from the U-ENDURE Long-Term Extension study
Ana Paula Lacerda, Sharanya Ford, Hiroshi Nakase, Fernando Aponte et al.
Citations
2 citations
Journal
Journal of Crohn s and Colitis
Topics
Inflammatory Bowel Disease
Field-Weighted Citation Impact (FWCI)
3.63
article
Efficacy and safety of upadacitinib maintenance therapy in patients with moderately to severely active Crohn’s disease: 2-year results from the U-ENDURE Long-Term Extension study
Ana Paula Lacerda, Sharanya Ford, Hiroshi Nakase, Fernando Aponte, Colla Cunneen, Vipul Jairath, Samuel I. Anyanwu, Elena Dubcenco, Fernando Magro, Edward V. Loftus, Geert D’Haens, Feng Tian, Édouard Louis, Benjamin Duncan, Miguel D. Regueiro, Irina Fish, Jenny Griffith, Irina Blumenstein
article en
2 citations
Abstract
No abstract available for this paper.
Publication Tag
Journal of Crohn s and ColitisVol. 19(8)
Institutions
Goethe University Frankfurt (DE), Western University (CA), Cleveland Clinic (US), Mayo Clinic (US), Sapporo Medical University (JP), University of Liège (BE), Universidade do Porto (PT), Cleveland Foundation (US), AbbVie (United States) (US), Hospital de São João (PT), Amsterdam Neuroscience (NL), Institute for Biomedicine (IT), Mayo Clinic in Arizona (US), University Hospital Frankfurt (DE), Centre Hospitalier Universitaire de Liège (BE), Centre for Health Technology and Services Research (PT), Amsterdam University Medical Centers (NL), University of Amsterdam (NL)